Search research articles
Contact Us
Filters
Showing results (571-580 of 762) with videos related to
Page
of 77
Sort By:
British Journal of Pharmacology
|
October 28, 2010
Spinal or systemic TY005, a peptidic opioid agonist/neurokinin 1 antagonist, attenuates pain with reduced tolerance
T M Largent-Milnes, T Yamamoto, P Nair, et al.
Annals of the New York Academy of Sciences
|
May 31, 1993
Structure-activity relationships of [Nle4, D-Phe7]alpha-MSH. Discovery of a tripeptidyl agonist exhibiting sustained bioactivity
T K Sawyer, A M Castrucci, D J Staples, et al.
Life Sciences
|
June 13, 2003
Design of novel peptide ligands which have opioid agonist activity and CCK antagonist activity for the treatment of pain
V J Hruby, R S Agnes, P Davis, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 1, 1980
4-Norleucine, 7-D-phenylalanine-alpha-melanocyte-stimulating hormone: a highly potent alpha-melanotropin with ultralong biological activity
T K Sawyer, P J Sanfilippo, V J Hruby, et al.
Journal of Medicinal Chemistry
|
November 15, 2002
Structure-activity studies of the melanocortin peptides: discovery of potent and selective affinity antagonists for the hMC3 and hMC4 receptors
Paolo Grieco, Antonio Lavecchia, Minying Cai, et al.
Peptides
|
January 1, 1994
The actions of melanin-concentrating hormone (MCH) on passive avoidance in rats: a preliminary study
R B McBride, B E Beckwith, R R Swenson, et al.
Life Sciences
|
May 11, 1987
Topical application of a melanotropic peptide induces systemic follicular melanogenesis
M E Hadley, S H Wood, A M Lemus-Wilson, et al.
Journal of Medicinal Chemistry
|
April 17, 2008
Design and microwave-assisted synthesis of novel macrocyclic peptides active at melanocortin receptors: discovery of potent and selective hMC5R receptor antagonists
Paolo Grieco, Minying Cai, Lu Liu, et al.
Bioorganic & Medicinal Chemistry
|
February 24, 2015
Design, synthesis, and biological evaluation of a series of bifunctional ligands of opioids/SSRIs
Mehr-un-Nisa, Munawar A Munawar, Yeon Sun Lee, et al.
Endocrinology
|
August 1, 1996
Low level cyclic adenosine 3',5'-monophosphate accumulation analysis of [des-His1, des- Phe6, Glu9] glucagon-NH2 identifies glucagon antagonists from weak partial agonists/antagonists
B A Van Tine, B Y Azizeh, D Trivedi, et al.
Page
of 77
Search research articles
Search
Showing results (571-580 of 762) with videos related to
Sort By:
Page
of 77
British Journal of Pharmacology
|
October 28, 2010
Spinal or systemic TY005, a peptidic opioid agonist/neurokinin 1 antagonist, attenuates pain with reduced tolerance
T M Largent-Milnes, T Yamamoto, P Nair, et al.
Annals of the New York Academy of Sciences
|
May 31, 1993
Structure-activity relationships of [Nle4, D-Phe7]alpha-MSH. Discovery of a tripeptidyl agonist exhibiting sustained bioactivity
T K Sawyer, A M Castrucci, D J Staples, et al.
Life Sciences
|
June 13, 2003
Design of novel peptide ligands which have opioid agonist activity and CCK antagonist activity for the treatment of pain
V J Hruby, R S Agnes, P Davis, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 1, 1980
4-Norleucine, 7-D-phenylalanine-alpha-melanocyte-stimulating hormone: a highly potent alpha-melanotropin with ultralong biological activity
T K Sawyer, P J Sanfilippo, V J Hruby, et al.
Journal of Medicinal Chemistry
|
November 15, 2002
Structure-activity studies of the melanocortin peptides: discovery of potent and selective affinity antagonists for the hMC3 and hMC4 receptors
Paolo Grieco, Antonio Lavecchia, Minying Cai, et al.
Peptides
|
January 1, 1994
The actions of melanin-concentrating hormone (MCH) on passive avoidance in rats: a preliminary study
R B McBride, B E Beckwith, R R Swenson, et al.
Life Sciences
|
May 11, 1987
Topical application of a melanotropic peptide induces systemic follicular melanogenesis
M E Hadley, S H Wood, A M Lemus-Wilson, et al.
Journal of Medicinal Chemistry
|
April 17, 2008
Design and microwave-assisted synthesis of novel macrocyclic peptides active at melanocortin receptors: discovery of potent and selective hMC5R receptor antagonists
Paolo Grieco, Minying Cai, Lu Liu, et al.
Bioorganic & Medicinal Chemistry
|
February 24, 2015
Design, synthesis, and biological evaluation of a series of bifunctional ligands of opioids/SSRIs
Mehr-un-Nisa, Munawar A Munawar, Yeon Sun Lee, et al.
Endocrinology
|
August 1, 1996
Low level cyclic adenosine 3',5'-monophosphate accumulation analysis of [des-His1, des- Phe6, Glu9] glucagon-NH2 identifies glucagon antagonists from weak partial agonists/antagonists
B A Van Tine, B Y Azizeh, D Trivedi, et al.
Page
of 77